Pharmaceutical systematics: Description and preliminary investigation of an alternative method for structuring drug information
Autor: | Brian Shepler, Matthew M. Murawski, Aleda M.H. Chen, Kristin R. Villa, Mary E. Kiersma |
---|---|
Rok vydání: | 2011 |
Předmět: |
Alternative methods
Drug medicine.medical_specialty business.industry Incidence (epidemiology) media_common.quotation_subject adverse drug reaction lcsh:RS1-441 Pharmacy Pharmacology medicine.disease lcsh:Pharmacy and materia medica Patient safety Emergency medicine Healthcare settings Medicine Medical prescription business adverse drug event health care economics and organizations Adverse drug reaction media_common |
Zdroj: | INNOVATIONS in Pharmacy, Vol 2, Iss 1 (2011) |
ISSN: | 2155-0417 |
Popis: | Objectives: To identify the 30 most common adverse drug events or reactions (ADE/ADRs) within the top 200 medications: (1) by raw incidence, (2) weighted by prescription volume, (3) and weighted by retail dollars. Methods: The Pharmacy Times Top 200 Medications (as ranked by prescription volume) was utilized to identify the top 200 medications in 2008. The ADE/ADRs for each medication were obtained from Facts and Comparisons, Micromedex, and Lexi-Comp and entered into a database. These ADE/ADRs were compiled and summed, identifying the number of times each appeared. These then were ranked to identify the 30 most common ADE/ADRs. The actual prescription volume and total retail dollars for each medication were obtained and listed next to each medication's ADE/ADR. The incidence of each ADE/ADR then was weighted by actual prescription volume and retail dollars to determine the top 30 most common ADE/ADRs. Results: Initial evaluation resulted in 9829 individual ADE/ADRs and summed into 1477 distinct ADE/ADRs, after adjusting for interchangeable terminology. Examples of the 30 most common ADE/ADRs (raw incidence) included: dizziness/vertigo, headache, nausea, vomiting, and diarrhea/loose stools. The list remained the same after weighting by actual prescription volume. After weighting by retail dollars, the order of ADE/ADRs changed slightly. Conclusion: Knowledge of ADE/ADRs is important for pharmacists in all healthcare settings. Consolidating ADE/ADRs for medications may enable pharmacists to recall the most common side effects and aid in earlier identification of ADE/ADRs, which may positively impact patient safety across practice settings. Type: Original Research |
Databáze: | OpenAIRE |
Externí odkaz: |